Germany's vaccination panel recommends doses for children aged 5-11

About 69.3% of the country's total population is fully vaccinated

vaccine
Representative image
AP Berlin
1 min read Last Updated : Dec 09 2021 | 9:26 PM IST

Germany's independent vaccination advisory panel on Thursday said it was recommending COVID-19 shots for children aged 5 to 11 with pre-existing conditions or who are in close contact to vulnerable people.

The expert panel also said that young kids without pre-existing conditions can be vaccinated if there is an individual desire to do so a step short of advising that all children in that age group get the shots.

The panel, known by its German acronym STIKO, said in a statement that children aged 5-11 should receive two doses of the Pfizer-BioNTech vaccine, three to six weeks apart.

The recommendation, which isn't binding and may still be amended after consultation with health officials, means doctors in Germany will likely begin offering vaccinations to younger children next week, when the appropriate shots become available.

About 69.3% of the country's total population is fully vaccinated.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronDelta variant of coronavirusCoronavirus VaccineVaccinationGermanyCoronavirus Tests

First Published: Dec 09 2021 | 9:26 PM IST

Next Story